tiprankstipranks
Advertisement
Advertisement

HCAT Stock Latest News

Health Catalyst completes sale of Vitalware for $147M
The FlyHealth Catalyst completes sale of Vitalware for $147M
1d ago
HCAT
Health Catalyst sees FY26 revenue $246M-$249M, consensus $266.93M
PremiumThe Fly
Health Catalyst sees FY26 revenue $246M-$249M, consensus $266.93M
1d ago
HCAT
Health Catalyst Sells VitalWare, Refocuses Core Operations
PremiumCompany Announcements
Health Catalyst Sells VitalWare, Refocuses Core Operations
1d ago
8K
HCAT
Health Catalyst reports Q2 adjusted EPS 4c, consensus 3c
PremiumThe Fly
Health Catalyst reports Q2 adjusted EPS 4c, consensus 3c
1d ago
HCAT
Health Catalyst sees Q3 revenue $55M-$56M, consensus $62.91M
PremiumThe Fly
Health Catalyst sees Q3 revenue $55M-$56M, consensus $62.91M
1d ago
HCAT
Health Catalyst price target raised to $2.50 from $1.75 at Citi
PremiumThe FlyHealth Catalyst price target raised to $2.50 from $1.75 at Citi
15d ago
HCAT
Health Catalyst price target raised to $3 from $2 at Canaccord
Premium
The Fly
Health Catalyst price target raised to $3 from $2 at Canaccord
17d ago
HCAT
Health Catalyst price target raised to $1.75 from $1 at Wells Fargo
Premium
The Fly
Health Catalyst price target raised to $1.75 from $1 at Wells Fargo
1M ago
HCAT
Health Catalyst: Vitalware Sale Seen as Value-Creating, Enabling Debt Paydown and Strategic Focus; Buy Rating and $2 Price Target Reiterated
PremiumRatings
Health Catalyst: Vitalware Sale Seen as Value-Creating, Enabling Debt Paydown and Strategic Focus; Buy Rating and $2 Price Target Reiterated
2M ago
HCAT
Health Catalyst Divests Vitalware to Strengthen Core Focus
PremiumCompany Announcements
Health Catalyst Divests Vitalware to Strengthen Core Focus
2M ago
8K
HCAT
Health Catalyst to divest Vitalware to Med-Metrix for $147M in cash
PremiumThe Fly
Health Catalyst to divest Vitalware to Med-Metrix for $147M in cash
2M ago
HCAT
Health Catalyst: Buy Rating Reaffirmed as Strategic Transformation Supports Long-Term Growth Despite Near-Term Estimate Cuts
PremiumRatings
Health Catalyst: Buy Rating Reaffirmed as Strategic Transformation Supports Long-Term Growth Despite Near-Term Estimate Cuts
3M ago
HCAT
Health Catalyst Earnings Call Maps Costly Transition
PremiumCompany AnnouncementsHealth Catalyst Earnings Call Maps Costly Transition
3M ago
HCAT
Health Catalyst: Buy Rating Reiterated on Project Nexus Progress, Margin Upside, and Unchanged $2 Price Target
Premium
Ratings
Health Catalyst: Buy Rating Reiterated on Project Nexus Progress, Margin Upside, and Unchanged $2 Price Target
3M ago
HCAT
Health Catalyst price target lowered to $1.75 from $2 at Stephens
Premium
The Fly
Health Catalyst price target lowered to $1.75 from $2 at Stephens
3M ago
HCAT
Health Catalyst reports Q1 adjusted EPS 2c, consensus 1c
PremiumThe Fly
Health Catalyst reports Q1 adjusted EPS 2c, consensus 1c
3M ago
HCAT
Health Catalyst sees Q2 revenue $68M-$70M, consensus $70.47M
PremiumThe Fly
Health Catalyst sees Q2 revenue $68M-$70M, consensus $70.47M
3M ago
HCAT
Health Catalyst sees FY26 revenue $260M-$265M, consensus $278.88M
PremiumThe Fly
Health Catalyst sees FY26 revenue $260M-$265M, consensus $278.88M
3M ago
HCAT
HCAT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
HCAT Upcoming Earnings Report: What to Expect?
3M ago
HCAT
Health Catalyst Adds Steve Nelson to Board of Directors
PremiumCompany AnnouncementsHealth Catalyst Adds Steve Nelson to Board of Directors
3M ago
8K
HCAT
Health Catalyst announces 9% global workforce reduction
Premium
The Fly
Health Catalyst announces 9% global workforce reduction
3M ago
HCAT
Health Catalyst Announces Restructuring and Workforce Reduction Plan
Premium
Company Announcements
Health Catalyst Announces Restructuring and Workforce Reduction Plan
3M ago
8K
HCAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >